Johnson & Johnson (JNJ) EV to EBIT (2009 - 2026)
Johnson & Johnson's (JNJ) quarterly EV to EBIT came in at 83.05 in Q2 2026, up 58.52% year-over-year from 52.39 in Q2 2025, and down 5.09% quarter-over-quarter from 87.5 in Q1 2026.
Analysis
Johnson & Johnson (JNJ) EV to EBIT (2009 - 2026) Analysis & Trends
Johnson & Johnson has disclosed EV to EBIT across 18 years of filings, most recently posting 83.05 for Q2 2026.
- In Q2 2026, EV to EBIT rose 58.52% year-over-year to 83.05; the TTM figure through Jun 2026 stood at 22.77 (up 40.36% YoY), while the FY2025 annual figure was 18.93, up 22.53% from the prior year.
- EV to EBIT came in at 83.05 for Q2 2026 at Johnson & Johnson, down from 87.5 in the prior quarter.
- In the past five years, EV to EBIT ranged from a high of 113.28 in Q3 2022 to a low of 50.44 in Q2 2024.
- Average EV to EBIT over 5 years is 74.02, with a median of 71.22 recorded in 2023.
- Year-over-year, EV to EBIT jumped 67.47% in 2022 and sank 38.81% in 2023.
- Over 5 years, EV to EBIT stood at 74.17 in 2022, then climbed by 12.47% to 83.42 in 2023, then increased by 8.15% to 90.22 in 2024, then decreased by 3.34% to 87.21 in 2025, then retreated by 4.77% to 83.05 in 2026.
- Per Business Quant data, the three most recent EV to EBIT figures were 83.05 in Q2 2026, 87.5 in Q1 2026, and 87.21 in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | BeOne Medicines | 40.49 Bn | 35.39 Bn | 1.53 Bn |
| 9 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 10 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 28, 2026 | 83.05 |
| Mar 29, 2026 | 87.50 |
| Dec 28, 2025 | 87.21 |
| Sep 28, 2025 | 58.92 |
| Jun 29, 2025 | 52.39 |
| Mar 30, 2025 | 57.44 |
| Dec 29, 2024 | 90.22 |
| Sep 29, 2024 | 73.12 |
| Jun 30, 2024 | 50.44 |
| Mar 31, 2024 | 59.99 |
| Dec 31, 2023 | 83.42 |
| Oct 1, 2023 | 61.22 |
| Jul 2, 2023 | 69.32 |
| Apr 2, 2023 | 66.16 |
| Jan 1, 2023 | 63.75 |
| Oct 2, 2022 | 74.17 |
| Jul 3, 2022 | 113.28 |
| Apr 3, 2022 | 100.76 |
| Oct 3, 2021 | 59.26 |
| Jul 4, 2021 | 67.64 |